Parker-Hannifin (PH) delivered mixed results in FY2026 on revenue of $78.9B versus the $79.5B estimate (-0.5% YoY) and EPS of $3.17. Below is the full Parker-Hannifin earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$78.9B (vs $79.5B est · -0.7% surprise · -0.5% YoY)
EPS
$3.17 (vs $2.95 est · +7.5% surprise · -0.6% YoY)
Share price
$446.40 (-1.5%)
Market cap
$1.37T
What you'll find
Next Parker-Hannifin (PH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Parker-Hannifin reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Parker-Hannifin (PH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Parker-Hannifin's next earnings date?
Parker-Hannifin's (PH) next scheduled earnings date is Feb 6, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Parker-Hannifin (PH) beat or miss earnings?
In FY2026, Parker-Hannifin (PH) posted mixed results — revenue of $78.9B versus the $79.5B estimate (-0.7% surprise) and EPS of $3.17 versus $2.95 expected (+7.5% surprise). Magnisto decodes every Parker-Hannifin (PH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Parker-Hannifin (PH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Parker-Hannifin (PH), anchored to the current $446.40 share price, so you can weigh the bull, base and bear cases for Parker-Hannifin side by side.
Is Parker-Hannifin (PH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Parker-Hannifin fits your own thesis and risk profile. This is research, not investment advice.